tirzepatide fda approves tirzepatide, Eli Lilly's new type 2 diabetes drug, and the company shares an estimated price FDA Says Shortage of GLP-1

Protein guidance is provided at initiation because GLP-1-driven appetite suppression reduces caloric intake broadly without adequate protein (typically 1.21.6g per kg body weight), you lose muscle alongside fat, and that's both metabolically and aesthetically wrong

Doctors also dont check B12 levels during routine blood work as most of the time its stored in the liver with years of stock, or its symptoms may get confused with the symptoms of other conditions

While not officially approved for weight loss, its sometimes prescribed off-label for that purpose

100% Natural | Gluten-Free | Vegan | No Corn Syrup

It is important to note that this doesnt mean a safety concern has been found

As a result, those taking GLP-1s can end up facing issues of malnutrition, or lacking a balanced diet that means they miss out on important vitamins or minerals that support scalp health